High Intensity Interval Training for Congenital Heart Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a home-based exercise program using the MedBIKE, a video game-linked exercise bike, can enhance fitness and health quality of life for children aged 10-18 with repaired congenital heart disease (CHD). CHD can limit exercise ability, which is associated with health issues later in life. The researchers aim to determine if high-intensity interval training (HIIT) can improve exercise capacity, similar to the benefits of cardiac rehab for adults. Children with repaired moderate to complex CHD who have not participated in similar programs before may be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve long-term health outcomes for children with CHD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this high-intensity interval training program is safe for children with congenital heart disease?
Research has shown that high-intensity interval training (HIIT) is generally safe for individuals with heart conditions, including congenital heart disease (CHD). One study found that HIIT improved exercise capacity and overall quality of life without major safety concerns. Another study demonstrated that using the MedBIKE™ for HIIT in children with CHD was both safe and practical. These findings suggest that the MedBIKE HIIT program is well-tolerated and can safely enhance heart health in young people with repaired CHD.12345
Why are researchers excited about this trial?
Unlike traditional treatments for congenital heart disease that often focus on medication or surgical intervention, the MedBIKE HIIT program introduces a new exercise approach. High-intensity interval training (HIIT) is distinct because it involves short bursts of intense activity followed by rest, which can improve heart function and fitness more efficiently than steady-state exercise. Researchers are excited about this method because it could offer a non-invasive, scalable way to enhance cardiovascular health and quality of life for patients with congenital heart disease, without the need for extensive medical interventions.
What evidence suggests that MedBIKE HIIT is effective for congenital heart disease?
Research has shown that the MedBIKE high-intensity interval training (HIIT) program, which participants in this trial will undergo, could benefit children with congenital heart disease (CHD). A small initial study found promising results, suggesting that the program might enhance exercise capacity and activity levels in these children. This is crucial because children with CHD often have reduced exercise ability, impacting their quality of life. Some studies also anticipate that MedBIKE HIIT will boost self-confidence and improve blood vessel health. These findings offer hope for using HIIT to help young people manage challenges related to CHD.12346
Who Is on the Research Team?
Michael Khoury, MD
Principal Investigator
University of Alberta
Are You a Good Fit for This Trial?
This trial is for children and teens aged 10-18 with repaired moderate-complex congenital heart disease. They must speak English, have space at home for the MedBIKE system, and not be restricted from exercising by their cardiologist. Those with severe symptoms, cognitive impairments affecting communication, or recent serious arrhythmias cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline assessments including TACQOL and CSAPPA questionnaires, EndoPAT testing, and CPET testing
Treatment
Participants undergo a 12-week, home-based HIIT program using the MedBIKE, with 3 sessions per week
Post-Intervention Assessment
Follow-up assessment including questionnaires, EndoPAT, CPET, and accelerometer wear
Follow-up
Participants are monitored for sustained changes in exercise capacity and secondary outcomes at 6 and 12 months post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- MedBIKE HIIT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Heart and Stroke Foundation of Canada
Collaborator